Asia-Pacific RT-PCR Technology Market Expected to Reach $2.38 Million by 2033

According to a new report published by Allied Market Research, titled, “Asia-Pacific RT-PCR Technology Market: Opportunity Analysis and Industry Forecast, 2024–2033," The Asia-Pacific RT-PCR technology market size was valued at $0.91 million in 2023 and is estimated to reach $2.38 million by 2033, exhibiting a CAGR of 10.1% from 2024 to 2033.

Reverse transcription polymerase chain reaction (RT-PCR) is a molecular biology technique that integrates the processes of reverse transcription and polymerase chain reaction (PCR) to amplify specific RNA sequences. In RT-PCR, RNA is first converted into complementary DNA (cDNA) using the enzyme reverse transcriptase. This cDNA then serves as a template for PCR amplification, allowing for the exponential increase of specific DNA fragments. This method is particularly valuable for quantifying gene expression levels by measuring the amount of RNA in a sample, which is often monitored in real-time through fluorescence detection techniques. RT-PCR has become important in both research and clinical diagnostics, enabling the analysis of gene expression, detection of viral RNA, and various applications in genetic disease diagnosis and cancer research.

The Asia-Pacific RT-PCR technology market is driven by a rise in demand for accurate diagnostics, particularly due to the high prevalence of infectious diseases and chronic health conditions. For instance, tuberculosis, hepatitis, and COVID-19 continue to impact the region significantly, creating a strong need for precise and reliable diagnostic methods. For instance, according to the Joint United Nations Program on HIV/AIDS (UNAIDS) epidemiological report, in 2023, 6.7 million [6.1 million–7.5 million] people living with HIV were residing in Asia-Pacific. RT-PCR technology’s high sensitivity and accuracy make it a key tool for pathogen detection and viral load monitoring, thus driving market growth by enhancing diagnostic precision and supporting advanced healthcare solutions.

In addition, the rise in technological advancements in RT-PCR also propels market growth by improving the technology's speed, accuracy, and ease of use. For example, multiplex RT-PCR, which allows simultaneous detection of multiple pathogens in a single test, has become increasingly popular in hospital settings, thus reducing testing time and resource utilization. Further, innovations such as portable RT-PCR devices enable rapid point-of-care testing in remote areas, broadening the technology's reach and appeal across diverse healthcare environments in Asia-Pacific, which further supports the market growth.

The Asia-Pacific RT PCR technology market is segmented into product, end user, application, and country. On the basis of the product, it is divided into instruments, reagent and consumables, and software and services. The reagent and consumables segment accounted for the largest share in terms of revenue in 2023, owing to high demand for specialized reagents, such as enzymes, primers, and probes, which are essential for accurate and efficient RT-PCR testing. In addition, the frequent replenishment of consumables driven by large-scale diagnostic applications and research needs further contributed to the segment's substantial market share.

However, the software and services segment is expected to register the highest CAGR during the forecast period. This is attributed to the increase in complexity of RT-PCR testing and growth in need for efficient data analysis tools. The rise in demand for real-time RT-PCR testing across clinical diagnostics and research sectors further boosts the adoption of advanced software solutions. In addition, the availability of cloud-based platforms and automation technologies is enhancing workflow efficiency and enabling remote monitoring in RT-PCR analysis. These advancements drive the growing demand for specialized software and services in the RT-PCR market.

On the basis of end user, the market is classified into academic and research institutes, pharmaceutical and biotechnological laboratories, hospitals and clinics, and others. The hospitals and clinics segment accounted for the largest share in terms of revenue in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to an increase in demand for accurate and rapid diagnostic testing in healthcare settings, especially for infectious diseases. Hospitals and clinics are adopting RT-PCR technology to enhance diagnostic capabilities and improve patient outcomes. In addition, government healthcare initiatives and investments in hospital infrastructure are further driving the adoption of RT-PCR technology in these facilities.

On the basis of application, the market is classified into clinical, research, forensic, and others. The clinical segment accounted for the largest share in terms of revenue in 2023 and is expected to register the highest CAGR during the forecast period. This is attributed to the increase in prevalence of infectious diseases, genetic disorders, and cancer, which drive the demand for accurate diagnostic tools. The adoption of RT-PCR technology in clinical settings allows for early detection, personalized treatment, and improved patient outcomes.

Country-wise, China dominated the market share in 2023. This was attributed to the large population, and significant government investments in public health initiatives, particularly in response to the COVID-19 pandemic. In addition, China has become a hub for medical and biotechnology research, thereby driving the adoption of RT-PCR technology in both clinical and research applications. The increasing demand for molecular diagnostics, along with advancements in diagnostic technology and manufacturing capabilities, further strengthened China’s position in the market.

However, India is expected to register the highest CAGR during the forecast period. This is attributed to the growing demand for accurate and affordable diagnostic solutions driven by an expanding population and rising healthcare needs. India’s increasing focus on improving healthcare infrastructure, coupled with government initiatives has accelerated the adoption of advanced diagnostic technologies such as RT-PCR. In addition, the rise in infectious diseases, genetic disorders, and the expansion of research in genomics and personalized medicine further contribute to India’s rapid market growth in the RT-PCR technology sector.

Key Findings of the Study

• On the basis of product, the reagent and consumables segment dominated the market in terms of revenue in 2023. However, the software and services segment is expected to register the highest CAGR during the forecast period.
• On the basis of end user, the hospitals and clinics segment dominated the market share in 2023 and is expected to register its highest CAGR during the forecast period.
• On the basis of application, the clinical segment dominated the market share in 2023 and is expected to register its highest CAGR during the forecast period.
• By country, China garnered the largest revenue share in 2023. However, India is anticipated to grow at the fastest CAGR during the forecast period.